JPRN-UMIN000010941已完成未知
Pharmacokinetics(PK) study of meropenem in Epithelial Lining Fluid (ELF), an open-label study - PK study of meropenem in ELF
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of hypersensitivity caused by lidocaine hydrochloride. 2) History of hypersensitivity caused by carbapenem. 3) In medication. 4) Creatinine clearance <=30mL/min. 5) Smorker. 6) Hepatic or Renal disorder, Anemia proved by the pre-medical test. 7)Any other participants whose condition is inappropriate for the evaluation of this clinical study, judged by the investigator.
研究者
相似试验
招募中
不适用
Population Pharmacokinetics of Meropenem in Critically Ill Infant PatientsCritically ill infant patientsBacterial InfectionsMeropenemTCTR20191106001The 90th Anniversary of Chulalongkorn University Fund40
进行中（未招募）
不适用
Meropenem fot the treatment of serious bacterial infections in neonates and young infantssuspected or proven late onset neonatal sepsisMedDRA version: 14.1Level: PTClassification code 10040049Term: Sepsis neonatalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-LTPENTA Foundation Onlus550
进行中（未招募）
1 期
Kinetic of Meropenem administration on 12 hours dailyEUCTR2019-003900-10-BECliniques universitaires Saint-Luc20
进行中（未招募）
不适用
How well does meropenem treat meningitis in infants below and including 90 days of ageEUCTR2011-001521-25-GBFONDAZIONE PENTA60
进行中（未招募）
不适用
Pharmacokinetics and safety of meropenem in the treatment of meningitis in neonates and young infantsproven or suspected bacterial meningitis in neonates and infants up to 90 days of ageMedDRA version: 14.1Level: LLTClassification code 10004049Term: Bacterial meningitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001521-25-NLPENTA Foundation (Fondazione Penta Onlus)60